• 1
    Mokdad, A. H., Ford, E. S., Bowman, B. A., et al (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 289: 7679.
  • 2
    Mokdad, A. H., Bowman, B. A., Ford, E. S., Vinicor, F., Marks, J. S., Koplan, JP. (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA. 286: 11951200.
  • 3
    Janssen, I., Katzmarzyk, P. T., Boyce, W. F., et al (2005) Comparison of overweight and obesity prevalence in school-aged youth from 34 countries and their relationships with physical activity and dietary patterns. Obes Rev. 6: 123132.
  • 4
    Ebbeling, C. B., Pawlak, D. B., Ludwig, DS. (2002) Childhood obesity: public-health crisis, common sense cure. Lancet. 360: 473482.
  • 5
    No authors listed (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 894 (i-xii): 1253.
  • 6
    Ohnishi, H., Saitoh, S., Takagi, S., et al (2006) Incidence of type 2 diabetes in individuals with central obesity in a rural Japanese population: the Tanno and Sobetsu Study. Diabetes Care. 29: 11281129.
  • 7
    Neligan, P. J., Fleisher, LA. (2006) Obesity and diabetes: evidence of increased perioperative risk? Anesthesiology. 104: 398400.
  • 8
    Ezenwaka, C. E., Kalloo, R. (2003) Indices of obesity, dyslipidemia, and insulin resistance in apparently healthy Caribbean subjects. J Clin Lab Anal. 17: 611.
  • 9
    Despres, JP. (1997) Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome. Exerc Sport Sci Rev. 25: 271300.
  • 10
    Pausova, Z. (2006) From big fat cells to high blood pressure: a pathway to obesity-associated hypertension. Curr Opin Nephrol Hypertens. 15: 173178.
  • 11
    Mufunda, J., Mebrahtu, G., Usman, A., et al (2006) The prevalence of hypertension and its relationship with obesity: results from a national blood pressure survey in Eritrea. J Hum Hypertens. 20: 5965.
  • 12
    Mann, D. M., Lee, J., Liao, Y., Natarajan, S. (2006) Independent effect and population impact of obesity on fatal coronary heart disease in adults. Prev Med. 42: 6672.
  • 13
    Misra, A., Vikram, N. K., Sharma, R., Basit, A. (2006) High prevalence of obesity and associated risk factors in urban children in India and Pakistan highlights immediate need to initiate primary prevention program for diabetes and coronary heart disease in schools. Diabetes Res Clin Pract. 71: 101102.
  • 14
    Roy, AJ. (2005) Sound the alarm: childhood obesity and the emergence of type 2 diabetes. Adv Nurse Pract. 13: 37402.
  • 15
    Ball, G. D., McCargar, LJ. (2003) Childhood obesity in Canada: a review of prevalence estimates and risk factors for cardiovascular diseases and type 2 diabetes. Can J Appl Physiol. 28: 117140.
  • 16
    Sinha, R., Fisch, G., Teague, B., et al (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 346: 802810.
  • 17
    Pinhas-Hamiel, O., Zeitler, P. (2005) The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 146: 693700.
  • 18
    Pinhas-Hamiel, O., Dolan, L. M., Daniels, S. R., Standiford, D., Khoury, P. R., Zeitler, P. (1996) Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 128: 608615.
  • 19
    Fagot-Campagna, A., Pettitt, D. J., Engelgau, M. M., et al (2000) Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr. 136: 664672.
  • 20
    Kershaw, E. E., Flier, JS. (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 89: 25482556.
  • 21
    Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, JM. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature. 372: 425432.
  • 22
    Matsuzawa, Y. (2006) The metabolic syndrome and adipocytokines. FEBS Lett. 580: 29172921.
  • 23
    Lau, D. C., Dhillon, B., Yan, H., Szmitko, P. E., Verma, S. (2005) Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol. 288: H2031H2041.
  • 24
    Hu, E., Liang, P., Spiegelman, BM. (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 271: 1069710703.
  • 25
    Nakano, Y., Tobe, T., Choi-Miura, N. H., Mazda, T., Tomita, M. (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo). 120: 803812.
  • 26
    Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., Lodish, HF. (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 270: 2674626749.
  • 27
    Shibata, R., Sato, K., Pimentel, D. R., et al (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med. 11: 10961103.
  • 28
    Cote, M., Mauriege, P., Bergeron, J., et al (2005) Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab. 90: 14341439.
  • 29
    Spranger, J., Kroke, A., Mohlig, M., et al (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet. 361: 226228.
  • 30
    Friedewald, W. T., Levy, R. I., Fredrickson, DS. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18: 499502.
  • 31
    Hara, K., Yamauchi, T., Kadowaki, T. (2005) Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans. Curr Diab Rep. 5: 136140.
  • 32
    Yamauchi, T., Kamon, J., Minokoshi, Y., et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 8: 12881295.
  • 33
    Yamauchi, T., Kamon, J., Waki, H., et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 7: 941946.
  • 34
    Punthakee, Z., Delvin, E. E., O'Loughlin, J., et al (2006) Adiponectin, adiposity and insulin resistance in children and adolescents. J Clin Endocrinol Metab. 91: 21192125.
  • 35
    Balagopal, P., George, D., Yarandi, H., Funanage, V., Bayne, E. (2005) Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. J Clin Endocrinol Metab. 90: 61926197.
  • 36
    Pischon, T., Girman, C. J., Hotamisligil, G. S., Rifai, N., Hu, F. B., Rimm, EB. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 291: 17301737.
  • 37
    Baratta, R., Amato, S., Degano, C., et al (2004) Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab. 89: 26652671.
  • 38
    Fu, Y., Luo, N., Klein, R. L., Garvey, WT. (2005) Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 46: 13691379.
  • 39
    Kondo, T., Kobayashi, I., Murakami, M. (2006) Effect of exercise on circulating adipokine levels in obese young women. Endocr J. 53: 189195.
  • 40
    Bluher, M., Bullen, J. W., Jr, Lee, J. H., et al (2006) Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab. 91: 23102316.
  • 41
    Kriketos, A. D., Gan, S. K., Poynten, A. M., Furler, S. M., Chisholm, D. J., Campbell, LV. (2004) Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care. 27: 629630.
  • 42
    Nassis, G. P., Papantakou, K., Skenderi, K., et al (2005) Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls. Metabolism. 54: 14721479.
  • 43
    Yokoyama, H., Emoto, M., Araki, T., et al (2004) Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes. Diabetes Care. 27: 17561758.
  • 44
    Hulver, M. W., Zheng, D., Tanner, C. J., et al (2002) Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab. 283: E861E865.
  • 45
    Ryan, A. S., Nicklas, B. J., Berman, D. M., Elahi, D. (2003) Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord. 27: 10661071.
  • 46
    Oberbach, A., Tonjes, A., Kloting, N., et al (2006) Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol. 154: 577585.
  • 47
    Esposito, K., Pontillo, A., Di Palo, C., et al (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 289: 17991804.
  • 48
    Unger, RH. (2003) The physiology of cellular liporegulation. Annu Rev Physiol. 65: 333347.
  • 49
    Unger, R. H., Orci, L. (2001) Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15: 312321.
  • 50
    Musi, N., Fujii, N., Hirshman, M. F., et al (2001) AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes. 50: 921927.
  • 51
    Nielsen, J. N., Jorgensen, S. B., Frosig, C., et al (2003) A possible role for AMP-activated protein kinase in exercise-induced glucose utilization: insights from humans and transgenic animals. Biochem Soc Trans. 31: 186190.